{"entity":{"type":"insider","cik":"0001357752","url":"/insider/0001357752","json_url":"/insider/0001357752.json","name":"Taub Robert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":3,"first":"2006-12-20","last":"2008-03-20","span_basis":"filed_date"},"name_variants":[{"name":"Taub Robert","source":"filing","n_filings":3,"first_seen":"2006-12-20","last_seen":"2008-03-20"}],"transactions":[{"id":3318418,"accession":"0001209191-08-019520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-019520","line_url":"/filing/0001209191-08-019520#line-2","is_derivative":false,"issuer_cik":"0001349426","issuer_name":"Omrix Biopharmaceuticals, Inc.","issuer_ticker":"OMRI","issuer_name_source":null,"issuer_url":"/issuer/0001349426","owner_cik":"0001357752","owner_name":"Taub Robert","owner_url":"/insider/0001357752","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26400.0,"shares_display":"26,400","price_per_share":12.1033,"price_display":"12.10","price_state":"stated","total_value":319527.12,"total_display":"319,527.12","shares_owned_after":2797103.0,"shares_owned_after_display":"2,797,103","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-20","filed_date":"2008-03-20","scope":"insider"},{"id":3318413,"accession":"0001209191-08-019520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-019520","line_url":"/filing/0001209191-08-019520#line-1","is_derivative":false,"issuer_cik":"0001349426","issuer_name":"Omrix Biopharmaceuticals, Inc.","issuer_ticker":"OMRI","issuer_name_source":null,"issuer_url":"/issuer/0001349426","owner_cik":"0001357752","owner_name":"Taub Robert","owner_url":"/insider/0001357752","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":53600.0,"shares_display":"53,600","price_per_share":12.3072,"price_display":"12.31","price_state":"stated","total_value":659665.92,"total_display":"659,665.92","shares_owned_after":2770703.0,"shares_owned_after_display":"2,770,703","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-19","filed_date":"2008-03-20","scope":"insider"},{"id":7988850,"accession":"0001209191-07-004055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-004055","line_url":"/filing/0001209191-07-004055#line-1","is_derivative":false,"issuer_cik":"0001349426","issuer_name":"Omrix Biopharmaceuticals, Inc.","issuer_ticker":"OMRI","issuer_name_source":null,"issuer_url":"/issuer/0001349426","owner_cik":"0001357752","owner_name":"Taub Robert","owner_url":"/insider/0001357752","role":"Director, Officer (Pres., Chief Executive Officer)","officer_title":"Pres., Chief Executive Officer","security_title":"Common Stock, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102391.0,"shares_display":"102,391","price_per_share":30.08,"price_display":"30.08","price_state":"stated","total_value":3079921.28,"total_display":"3,079,921.28","shares_owned_after":1210262.0,"shares_owned_after_display":"1,210,262","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-01-17","filed_date":"2007-01-18","scope":"insider"},{"id":2638023,"accession":"0001209191-06-066152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-066152","line_url":"/filing/0001209191-06-066152#line-2","is_derivative":false,"issuer_cik":"0001349426","issuer_name":"Omrix Biopharmaceuticals, Inc.","issuer_ticker":"OMRI","issuer_name_source":null,"issuer_url":"/issuer/0001349426","owner_cik":"0001357752","owner_name":"Taub Robert","owner_url":"/insider/0001357752","role":"Director, Officer (Pres., Chief Executive Officer)","officer_title":"Pres., Chief Executive Officer","security_title":"Common Stock, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":682606.0,"shares_display":"682,606","price_per_share":30.08,"price_display":"30.08","price_state":"stated","total_value":20532788.48,"total_display":"20,532,788.48","shares_owned_after":1312653.0,"shares_owned_after_display":"1,312,653","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-12-20","filed_date":"2006-12-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001349426","name":"Omrix Biopharmaceuticals, Inc.","url":"/issuer/0001349426","role":"Director, Officer (Chief Executive Officer)","n_filings":3,"first_seen":"2006-12-20","last_seen":"2008-03-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001357752","retrieved_at":"2026-08-21T04:48:44+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}